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Incidence rates of classical Kaposi's sarcoma and
multiple myeloma do not correlate
H Hjalgrim, M Frisch and M Melbye
Departnent of Epidemiology Research. Danish Epidemiology Science Centre. Statens Serum Institut. 5 Artillerivej. DK-2300 Copenhagen. Denmark
Summary We compared population-based incidence rates for classical Kaposis sarcoma and multiple myeloma. Neither for men
(Spearman's rank correlation coefficient (r) = 0.01, P = 0.97, 13 pairs) nor for women (r= 0.24, P = 0.42, 13 pairs) did the incidences of the
two conditions correlate. This absence of correlation does not support the hypothesis that Kaposi's sarcoma and multiple myeloma share a
common aetiology, such as HHV-8.
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RecentIv. a molecular studv of bone marrow tissue from patients
,with multiple myeloma (MM) suggested that this condition should
be added to the list of diseases presumably caused by human
herpesvirus-8 (HHV-8) (Rettig et al. 1997a). Prexvious follow--up
studies ofpatients w-ith Kaposi's sarcoma (KS) haxe provided little
exidence to suggest that these patients are at increased risk of MM
(Grulich et al. 1992: Biggar et al. 1994: Hjalgrim et al. 1997).
Estimates of the prevalence of HHV-8 currentlx exist for a fewx
populations only. and accordingly it is not possible to relate such
measures to MM occurrence. How-ever. reliable incidence rates of
classical KS haxe become axvailable for many geographical
regions. demonstrating a substantial variation (HjalIggim et al.
1998). Studies of different groups at increased risk of KS. e.g.
HIV-infected patients. have indicated that prexalence of HHV-8
correlates with KS occurrence (Gao et al. 1996: Simpson et al.
1996). This suggests that disease occurrence may reflect xirus
prevalence. We therefore hypothesized that if HHV-8 x ere
causally involxed in the pathogenesis of MM. incidence rates of
MIM and classical KS would correlate.
did not correlate. This applied to analyses of paired data (men and
xwomen together) (r= 0.15. P = 0.46). as well as to separate analyses
for men (r = 0.01. P = 0.97) and women (r = 0.24. P = 0.42).
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MATERIAL AND METHODS
Crude incidence rates for M-M in different populations for the
period 1978-82 wxere obtained from Cancer Incidence in File
Continents (Muir et al. 1987) (Figure 1). These wxere paired with
corresponding rates ofclassical KS (crude or standardized to local
populations) axailable in the literature or from recent studies ofKS
in the Scandinavian countries (Figrure 1). Correlation betmeen the
rates for the tu-o conditions xxas tested by means of Spearman's
rank test.
RESULTS
A total of 13 pairs ofincidence rates for KS andMM were identified
forboth men and wxomen (Figure 1). The occurrences ofKS and WM
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Figure 1 Crude inidxence rates of multiple myeloma by corresponding rates
for classical Kaposi's sarcoma. Periods and sources for Kaposi's sarcoma
incidence rates: UK 1971-0 (Grulich et al] 1992): Australia 1972-82 (Kaidor
et al. 1994): USA and Puerto Rico 1973-79 (Bkggar et al. 1984): Ragusa.
Italy. 1981-84, Parma, Italy, 1978-84 and Varese. Italy, 1976-84 (Geddes et
al. 1994): Iceland. 1975-79 (Hjalgrim et al. 1998). Crude rates for Denmark.
Sweden. Norway and Finland. all 1978-79. have been extracted from
(Hjalgrim et al. 1996). Data from the Swiss canton of Vaud were included in
the analyses. but do not appear in the figure (Levi et al. 1993)
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DISCUSSION
Since the initial description ofHHV-8 in 1994 (Chang et al. 1994).
there has been an intense search for conditions potentially caused
by the virus. Beside KS. there is, at present. evidence to suggest
that HHV-8 is involved in the pathogenesis ofCastleman's disease
(Dupin et al. 1995) andprimary effusion lymphomas (Cesarman et
al. 1995). Most recently. it has been suggested that HHV-8 may
also be involved in the development ofMM (Brousset et al. 1997:
Rettig et al. 1997a and b: Said et al. 1997: Tisdale et al. 1997). The
present study. however. finds that population-based incidence rates
of classical KS and MM do not correlate. This result is in accor-
dance with serological and molecular studies ofpatients with MM
demonstrating no unusual prevalence of HHV-8 in this group of
patients (Cesarman et al. 1995: Pastore et al. 1995: Cook et al.
1997: MacKenzie et al. 1997: Marcelin et al. 1997; Masood et al.
1997: Parravicini et al. 1997: Whitby et al. 1997). Similarly.
follow-up studies of patients with classical or AIDS-related KS
have not provided data indicative of an increased risk of MM
among such patients (Grulich et al. 1992: Biggar et al. 1994:
Hjalgrim et al. 1997).
The present study has certain limitations. For instance. some
geographical variation in completeness ofregistration ofMM and
KS may exist. Moreover, while only crude incidence rates ofMM
are included in the analyses. a few ofthe KS incidence rates were
standardized to local populations. as of 1970 (USA and Iceland). It
is unlikely, however. that this has had any influence on the
apparent absence of correlation between KS and MM incidence
rates.
We therefore conclude that the hypothesis that KS and MM
share a common aetiology. such as HHV-8. is not supported by
currently available epidemiological evidence. However, we cannot
rule out the possibility that different strains of HHV-8 may cause
different diseases. e.g. KS and MM. as has been suggested recently
(Luppi et al. 1997).
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